
Keywords: پروموتر سیتومگالوویروس; Vaccine; VZV; RSV; Next generation vaccine; BAC; bacterial artificial chromosome; CMVp; cytomegalovirus promoter; IFA; immunofluorescence analysis; PFU; plaque-forming unit; RSV; respiratory syncytial virus; RSV G; RSV glycoprotein; RSV F; RSV fusion glyc